Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release

Journal of Clinical Investigation

Volumn 104, Issue 1, 1999, Pages 67-72

  Hostens, Katleen ^a   Pavlovic, Dejan ^a   Zambre, Yasmeeni ^a   Ling, Zhidong ^a   Van Schravendijk, Christiaan ^a   Eizirik, Décio L ^a   Pipeleers, Daniel G ^a  

^a DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; PROINSULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032740992     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6438     Document Type: Article

References (31)

1. Bottazzo, G.F., et al. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313:353-360.
2. Rabinovitch, A. 1993. Roles of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Reviews. 1:215-240.
3. Mandrup-Poulsen, T. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1005-1029.
4. Rabinovitch, A., Suarez-Pinzon, W., El Seikh, A., Sorensen, O., and Power, R.F. 1996. Cytokine gene expression in pancreatic islet-infiltration leukocytes of BB rats: expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes. 45:749-754.
5. Jiang, Z., and Woda, B. A. 1991. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J. Immunology. 146:2990-2994.
6. Hirasawa, K., et al. 1997. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 71:4024-4031.
7. Foulis, A.K., Farquharson, M.A., and Meager, A. 1987. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 2:1423-1427.
8. Foulis, A.K., McGill, M., and Farquharson, M.A. 1991. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes, and interferon-g containing cells. J. Pathol. 165:97-103.
9. Huang, X., et al. 1995. Interferon expression in the pancreases of patients with type I diabetes. Diabetes. 44:658-664.
10. Hussain, M.J., Peakman, M., and Gallati, H. 1996. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia. 39:60-69.
11. Delaney, C.A., Pavlovic, D., Hoorens, A., Pipeleers, D., and Eizirik, D.L. 1997. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology. 138:2610-2614.
12. Ræder, M.E., et al. 1994. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. J. Clin. Endoctrinol. Metab. 79:1570-1575.
13. Spinas, G.A., Snorgaard, O., Hartling, S.G., Oberholzer, M., and Berger, W. 1992. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care. 15:632-637.
14. Hartling, S.G., Lindgren, F., Dahlqvist, G., Persson, B., and Binder, B. 1989. Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes. 38:1271-1274.
15. Heaton, D.A., et al. 1988. Increased proinsulin Levels as an early indicator of β-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia. 31:182-184.
16. Keymeulen, B., et al. 1998. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia. 41:452-459.
17. Ling, Z., and Pipeleers, D. 1996. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading ro a loss of glucose regulation. J. Clin. Invest. 98:2805-2812.
18. Eizirik, D.L., et al. 1994. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin. Invest. 93:1968-1974.
19. Southern, C., Schulster, D., and Green, I.C. 1990. Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an 1-arginine dependent nitric oxide generating mechanism. FEBS Lett. 276:42-44.
20. 15N)nitrate in biological fluids. Anal. Biochem. 126:131-138.
21. Zambre, Y., et al. 1998. Effect of glucose on production and release of proinsulin conversion products by cultured human islets. J. Clin. Endocrinol. Metab. 83:1234-1238.
22. Kiekens, R., et al. 1992. Differences in glucose recognition by individual rat pancreatic ß cells are associated wirh intercellular differences in glucose-induced biosynthetic activity. J Clin. Invest. 89:117-125.
23. Pipeleers, D.G., et al. 1985. Interplay of nutrients and hormones in the regulation of insulin release. Endocrinology. 117:824-833.
24. Bowsher, R.R., Wolny, J.D., and Frank, B.H. 1992. A rapid and sensitive radi oimmunoassay for the measurement of proinsulin in human serum. Diabetes. 41:1084-1090.
25. Ling, Z., et al. 1998. Intercellular differences in interleukin 1β-induced suppression of insulin synthesis and stimulation of non-insulin protein synthesis by rat pancreatic α cells. Endocrinology. 139:1540-1545.
26. Köhler, T. 1995. Design of suitable primers and competitor fragments for quantitative PCR. In Quantitation of mRNA by polymerase chain reaction: nonradioactive PCR methods. D. Laßner, A-K. Rost, B. Thamm, B. Pustowoit, and H. Remke, editors, Springer-Verlag, Berlin, Germany. 15-24.
27. Alarcon, C., Leahy, J.L., Schuppin, G.T., and Rhodes, C.J. 1995. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin dependent diabetes mellitus. J. Clin. Invest. 95:1032-1039.
28. Gadot, M., Ariav, Y., Cerasi, E., Kaiser, N., and Gross, D.J. 1995. Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the β cell. Endocrinology. 136:4218-4223.
29. Seaquist, E.Z., et al. 1996. Hyperproinsulinemia is associated with increased β cell demand after hemipancrearecromy in humans. J. Clin. Invest. 97:455-460.
30. Rhodes, C.J., and Alarcon, C. 1994. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes. 43:511-517.
31. Gross, D.J., Leibowitz, G., Cerasi, E., and Kaiser, N. 1996. Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure. Endocrinology. 137:5610-5615.